Evio, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by GLAUSER LORI JEAN, was filed 12 Sept 2017.
Evio, Inc.: what insiders have been doing
This page follows insider dealings at Evio, Inc. as filed with SEC (Form 4). Nothing new has been filed by managers of Evio, Inc. in twelve months, the latest record being from 5 February 2020.
Since 2017, the database holds 2 purchases and no sales by insiders of the company.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Since the insiders bought
- -9.4%Entry US$0.97 · Close at T+365 US$0.88
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
- 1,820,881 shares@ US$0.0715100.0% of flowCommon StockSEC:0001493152-20-001642:0
- 3,029,007 shares@ US$0.0715100.0% of flowCommon StockSEC:0001493152-20-001641:0
- 2,503,650 shares@ US$0.0715100.0% of flowCommon StockSEC:0001493152-20-001539:0
- 5,000 shares@ US$1.052.5% of flowCommon StockSEC:0001477932-17-004434:0Canonical exit: 7 Dec 2017 (T+90)
- 8,667 shares@ US$1.064.4% of flowCommon StockSEC:0001477932-17-004402:0Canonical exit: 6 Dec 2017 (T+90)
5 of 5 declarations
About Evio, Inc.
Evio, Inc. is a company listed on the XNAS market, specializing in testing and analysis services for the cannabis industry. It provides compliance and quality solutions for cannabis producers and distributors.
